Background
* Dark
* Neutral 0
* Linear Gradient
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Text styles
Light Text
* Color Default
* Neutral 60
* Neutral 15
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Text styles
Dark Text
*Color Inverted Default
* Inverted Neutral 60
* Inverted Neutral 15
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Text styles
* Body M ( Regular)
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Layout
* Left
* Center
* Center
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Node-positive: 5-year risk of distant recurrence (premenopausal patients with a RS result of 0-100 and postmenopausal patients with a RS result of 0-25). 5-year risk of distant recurrence or mortality (postmenopausal patients with a RS result of 26-100)
Mobile visualization
* Centered
* Light
* Dark
Node-negative: 9-year distant recurrence risk for node-negative patients (RS result 0-100)
Node-positive: 5-year distant recurrence risk of premenopausal patients (RS result-100) and postmenopausal patients (RS of 0-25)
5-year distant recurrence or mortality risk for postmenopausal patients (RS of 26-100)
Node-positive: 5-year distant recurrence risk of premenopausal patients (RS result-100) and postmenopausal patients (RS of 0-25)
5-year distant recurrence or mortality risk for postmenopausal patients (RS of 26-100)
Node-negative: 9-year distant recurrence risk for node-negative patients (RS result 0-100)
Node-positive: 5-year distant recurrence risk of premenopausal patients (RS result-100) and postmenopausal patients (RS of 0-25)
5-year distant recurrence or mortality risk for postmenopausal patients (RS of 26-100)
Node-positive: 5-year distant recurrence risk of premenopausal patients (RS result-100) and postmenopausal patients (RS of 0-25)
5-year distant recurrence or mortality risk for postmenopausal patients (RS of 26-100)
Node-negative: 9-year distant recurrence risk for node-negative patients (RS result 0-100)
Node-positive: 5-year distant recurrence risk of premenopausal patients (RS result-100) and postmenopausal patients (RS of 0-25)
5-year distant recurrence or mortality risk for postmenopausal patients (RS of 26-100)
Node-positive: 5-year distant recurrence risk of premenopausal patients (RS result-100) and postmenopausal patients (RS of 0-25)
5-year distant recurrence or mortality risk for postmenopausal patients (RS of 26-100)